Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1
Joslin Diabetes Center · Beth Israel Deaconess Medical Center · +1 more institution
Abstract
Type 2 diabetes mellitus (DM) is characterized by insulin resistance and pancreatic beta cell dysfunction. In high-risk subjects, the earliest detectable abnormality is insulin resistance in skeletal muscle. Impaired insulin-mediated signaling, gene expression, glycogen synthesis, and accumulation of intramyocellular triglycerides have all been linked with insulin resistance, but no specific defect responsible for insulin resistance and DM has been identified in humans. To identify genes potentially important in the pathogenesis of DM, we analyzed gene expression in skeletal muscle from healthy metabolically characterized nondiabetic (family history negative and positive for DM) and diabetic Mexican-American…
Citation impact
- FWCI
- 42.82
- Percentile
- 100%
- References
- 55
Authors
17- MPMary‐Elizabeth PattiCorresponding
Joslin Diabetes Center, Beth Israel Deaconess Medical Center, The University of Texas at San Antonio Health Science Center
- AJAtul J. Butte
Joslin Diabetes Center, Beth Israel Deaconess Medical Center, The University of Texas at San Antonio Health Science Center
- SCSarah Crunkhorn
Joslin Diabetes Center, Beth Israel Deaconess Medical Center, The University of Texas at San Antonio Health Science Center
- KCKenneth Cusi
Joslin Diabetes Center, Beth Israel Deaconess Medical Center, The University of Texas at San Antonio Health Science Center
- RBRachele Berria
Joslin Diabetes Center, Beth Israel Deaconess Medical Center, The University of Texas at San Antonio Health Science Center
Topics & keywords
- Insulin resistance
- NRF1
- Endocrinology
- Internal medicine
- Biology
- Insulin
- Diabetes mellitus
- Skeletal muscle
- Good health and well-being
Funding
- ADAmerican Diabetes AssociationAward: DK24092
- IFIacocca Family Foundation
- MIMassachusetts Institute of Technology
- DKDeutsches Krebsforschungszentrum
- EFEndocrine Fellows FoundationAward: DK24092
- NINational Institutes of HealthAward: DK24092
- NINational Institute of Diabetes and Digestive and Kidney Diseases